WHO Expert Committee on Biological Standardization. Sixty-third report
- PMID: 24669583
WHO Expert Committee on Biological Standardization. Sixty-third report
Abstract
This report presents the recommendations of a WHO Expert Committee commissioned to coordinate activities leading to the adoption of international recommendations for the production and control of vaccines and other biologicals, and the establishment of international biological reference materials. Following a brief introduction, the report summarizes a number of general issues brought to the attention of the Committee. The next part of the report, of particular relevance to manufacturers and national regulatory authorities, outlines the discussions held on the development of revised WHO Recommendations and Guidelines for a number of vaccines, blood products and related substances. Specific discussion areas included the development of WHO guidance on the quality, safety and efficacy of poliomyelitis vaccines; recombinant malaria vaccines; diphtheria vaccines; tetanus vaccines; combined vaccines based on diphtheria and tetanus vaccines; and Japanese encephalitis vaccines. Subsequent sections of the report then provide information on the current status and proposed development of international reference materials in the areas of vaccines and related substances; blood products and related substances; in vitro diagnostic device reagents; biotherapeutics other than blood products; and antibiotics. A series of annexes are then presented which include an updated list of WHO Recommendations, Guidelines and other documents on biological substances used in medicine (Annex 1), followed by a series of WHO Recommendations and Guidelines adopted on the advice of the Committee (Annexes 2-7). All additions made during the meeting to the list of International Standards and Reference Reagents for biological substances maintained by WHO are then summarized in Annex 8, and are also available at: http://www. who.int/biologicals.
Similar articles
-
WHO Expert Committee on Biological Standardization.World Health Organ Tech Rep Ser. 2013;(979):1-366, back cover. World Health Organ Tech Rep Ser. 2013. PMID: 24340361
-
WHO Expert Committee on Biological Standardization. Sixty-fifth report.World Health Organ Tech Rep Ser. 2015;(993):1-262. World Health Organ Tech Rep Ser. 2015. PMID: 26714369
-
WHO Expert Committee on Biological Standardization.World Health Organ Tech Rep Ser. 2014;(987):1-266, back cover. World Health Organ Tech Rep Ser. 2014. PMID: 25167682
-
Evaluation of cell substrates for the production of biologicals: Revision of WHO recommendations. Report of the WHO Study Group on Cell Substrates for the Production of Biologicals, 22-23 April 2009, Bethesda, USA.Biologicals. 2010 Jan;38(1):162-9. doi: 10.1016/j.biologicals.2009.08.019. Epub 2009 Oct 8. Biologicals. 2010. PMID: 19818645 Review.
-
[Diagnostic kits in parasitology: which controls?].Parassitologia. 2004 Jun;46(1-2):145-9. Parassitologia. 2004. PMID: 15305705 Review. Italian.
Cited by
-
Integrating 3Rs approaches in WHO guidelines for the batch release testing of biologicals: Responses from a survey of National Control Laboratories and National Regulatory Authorities.Biologicals. 2023 Nov;84:101721. doi: 10.1016/j.biologicals.2023.101721. Epub 2023 Nov 1. Biologicals. 2023. PMID: 37922625 Free PMC article.
-
Handheld Point-of-Care Devices for Snakebite Coagulopathy: A Scoping Review.Thromb Haemost. 2025 May;125(5):405-420. doi: 10.1055/a-2407-1400. Epub 2024 Aug 30. Thromb Haemost. 2025. PMID: 39214143 Free PMC article.
-
Factors Influencing Persistence of Diphtheria Immunity and Immune Response to a Booster Dose in Healthy Slovak Adults.Vaccines (Basel). 2019 Oct 7;7(4):139. doi: 10.3390/vaccines7040139. Vaccines (Basel). 2019. PMID: 31591336 Free PMC article.
-
Hepatitis D: challenges in the estimation of true prevalence and laboratory diagnosis.Gut Pathog. 2021 Oct 30;13(1):66. doi: 10.1186/s13099-021-00462-0. Gut Pathog. 2021. PMID: 34717740 Free PMC article. Review.
-
WHO working group meeting to develop WHO Recommendations to assure the quality, safety and efficacy of enterovirus 71 vaccines.Vaccine. 2020 Jul 6;38(32):4917-4923. doi: 10.1016/j.vaccine.2020.05.001. Epub 2020 May 4. Vaccine. 2020. PMID: 32418797 Free PMC article.